Webinar Video | Life Sciences Session #4: How to optimise your regulatory exclusivity rights for pharmaceutical products?
In the fourth online Life Sciences Session our experts, Kirian Claeyé and Laura Traest, will be focusing on regulatory exclusivity rights for pharmaceutical products, which will include data exclusivity, orphan exclusivity, SPCs and paediatric rewards. They will navigate the maze of regulatory exclusivity rights, update you on a number of significant recent developments, and discuss what is still to come. Specific topics will include:
- The SPC manufacturing waiver
- The CJEU’s latest case-law on SPC rights: Santen and Royalty Pharma
- The European Commission’s review of Orphan Exclusivity and Paediatric Extensions
- The General Court’s very recent Polpharma ruling on Data Exclusivity
Contact
Recommended articles
Hospital mergers no longer subject to the Belgian Competition Authority’s prior review
The legislator has now had the last word, by providing that, in principle, hospital mergers are no longer subject to the BCA’s prior review and approval.
Read on
EU citizens rally for medical cannabis but face a rigid European Commission
In the EU, access to medical cannabis is a matter of national policy. A group of citizens wants to change that by leveraging a citizens’ initiative and prompting the European Commission to act.
Read on
WEBINAR VIDEO | Belgium’s medicines reimbursement reform
During this webinar, Kirian Claeyé and Bart Junior Bollen guide you through the eagerly anticipated reform of the reimbursement procedures for medicines in Belgium.
Read on